The potential application and challenge of powerful CRISPR/Cas9 system in cardiovascular research

被引:9
|
作者
Li, Yangxin [1 ,2 ]
Song, Yao-Hua [3 ]
Liu, Bin [4 ]
Yu, Xi-Yong [5 ]
机构
[1] Soochow Univ, Affiliated Hosp 1, Inst Cardiovasc Sci, Suzhou 215123, Jiangsu, Peoples R China
[2] Soochow Univ, Affiliated Hosp 1, Dept Cardiovasc Surg, Suzhou 215123, Jiangsu, Peoples R China
[3] Soochow Univ, Affiliated Hosp 1, Collaborat Innovat Ctr Hematol, Cyrus Tang Hematol Ctr,Jiangsu Inst Hematol, Suzhou 215123, Jiangsu, Peoples R China
[4] Jilin Univ, Hosp 2, Dept Cardiol, Changchun 130041, Jilin, Peoples R China
[5] Guangzhou Med Univ, Guangdong Cardiovasc Inst, Guangzhou 510080, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
CRISPR/Cas9; Gene regulation; Gene therapy; Stern cell; Cardiovascular research; ONE-STEP GENERATION; ENDOTHELIAL-CELLS; GENOME; MICE; KNOCKOUT; PLATFORM; COMPLEX; MONKEY; PCSK9; RNA;
D O I
10.1016/j.ijcard.2016.11.177
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
CRISPR/Cas9 is a precision-guided munition found in bacteria to fight against invading viruses. This technology has enormous potential applications, including altering genes in both somatic and germ cells, as well as generating knockout animals. Compared to other gene editing techniques such as zinc finger nucleases and TALENS, CR1SPR/Cas9 is much easier to use and highly efficient. Importantly, the multiplex capacity of this technology allows multiple genes to be edited simultaneously. CRISPR/Cas9 also has the potential to prevent and cure human diseases. In this review, we wish to highlight some key points regarding the future prospect of using CRISPRICas9 as a powerful tool for cardiovascular research, and as a novel therapeutic strategy to treat cardiovascular diseases. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:191 / 193
页数:3
相关论文
共 50 条
  • [1] CRISPR/Cas9: a powerful tool in colorectal cancer research
    Hu, Yang
    Liu, Liang
    Jiang, Qi
    Fang, Weiping
    Chen, Yazhu
    Hong, Yuntian
    Zhai, Xiang
    [J]. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2023, 42 (01)
  • [2] CRISPR/Cas9: a powerful tool in colorectal cancer research
    Yang Hu
    Liang Liu
    Qi Jiang
    Weiping Fang
    Yazhu Chen
    Yuntian Hong
    Xiang Zhai
    [J]. Journal of Experimental & Clinical Cancer Research, 42
  • [3] Application of CRISPR/Cas9 to Autophagy Research
    O'Prey, J.
    Sakamaki, J.
    Baudot, A. D.
    New, M.
    Van Acker, T.
    Tooze, S. A.
    Long, J. S.
    Ryan, K. M.
    [J]. MOLECULAR CHARACTERIZATION OF AUTOPHAGIC RESPONSES, PT B, 2017, 588 : 79 - 108
  • [4] Potential Application of the CRISPR/Cas9 System against Herpesvirus Infections
    Chen, Yuan-Chuan
    Sheng, Jingxue
    Phong Trang
    Liu, Fenyong
    [J]. VIRUSES-BASEL, 2018, 10 (06):
  • [5] CRISPR/Cas9: From research to therapeutic application
    Ben Yacoub, T.
    Wohlschlegel, J.
    Sanel, J. -A.
    Zeitz, C.
    Audo, I.
    [J]. JOURNAL FRANCAIS D OPHTALMOLOGIE, 2023, 46 (04): : 398 - 407
  • [6] Application of CRISPR/Cas9 technology in sepsis research
    Wu, Miao
    Hu, Niandan
    Du, Xianjin
    Wei, Jie
    [J]. BRIEFINGS IN FUNCTIONAL GENOMICS, 2020, 19 (03) : 229 - 234
  • [7] Application of the CRISPR/Cas9 system in Dioscorea zingiberensis
    Shan Feng
    Wei Song
    Ruirui Fu
    Hong Zhang
    Anran Xu
    Jiaru Li
    [J]. Plant Cell, Tissue and Organ Culture (PCTOC), 2018, 135 : 133 - 141
  • [8] Application and optimization of the CRISPR/Cas9 system in grape
    Ren, C.
    Gathunga, E. K.
    Li, S.
    Liang, Z.
    [J]. PROCEEDINGS OF THE XII INTERNATIONAL CONFERENCE ON GRAPEVINE BREEDING AND GENETICS, 2019, 1248 : 149 - 153
  • [9] Application of the CRISPR/Cas9 system in Dioscorea zingiberensis
    Feng, Shan
    Song, Wei
    Fu, Ruirui
    Zhang, Hong
    Xu, Anran
    Li, Jiaru
    [J]. PLANT CELL TISSUE AND ORGAN CULTURE, 2018, 135 (01) : 133 - 141
  • [10] The application of CRISPR/Cas9 system in cervical carcinogenesis
    Gao, Chun
    Wu, Ping
    Yu, Lan
    Liu, Liting
    Liu, Hong
    Tan, Xiangyu
    Wang, Liming
    Huang, Xiaoyuan
    Wang, Hui
    [J]. CANCER GENE THERAPY, 2022, 29 (05) : 466 - 474